COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,008 Articles (21,508 medRxiv, 7,500 bioRxiv)

Most recent first Previous |  Page 1492: Articles 14911-14920  | Next

The role of connectivity on COVID-19 preventive approaches
Miro Pina, V., Nava-Trejo, J. E., Tobias, A., Nzabarushimana, E., Gonzalez-Casanova, A., Gonzalez-Casanova, I.
10.1101/2021.03.11.21253348 — Posted: 2021-03-12
Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.
Patone, M., Thomas, K., Hatch, R., Tan, P. S., Liao, W., Coupland, C., Mouncey, P., Harrison, D., Rowan, K., Horby, P., Watkinson, P., Hippisley-Cox, J.
10.1101/2021.03.11.21253364 — Posted: 2021-03-12 Discussion: Offsite
Dynamic versus Continuous Interventions: Optimizing Lockdown Policies for COVID-19
Akinci, K., Fdez, J., Pena-Tapia, E., Witkowski, O.
10.1101/2021.03.10.21253324 — Posted: 2021-03-12
Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City
Antonio-Villa, N. E., Fernandez-Chirino, L., Pisanty-Alatorre, J., Mancilla-Galindo, J., Kammar-Garcia, A., Vargas-Vazquez, A., Gonzalez-Diaz, A., Fermin-Martinez, C. A., Marquez-Salinas, A., Canedo Guerra, E., Bahena-Lopez, J. P., Villanueva-Reza, M., Marquez-Sanchez, J., Jaramillo-Molina, M. E., Gutierrez-Robledo, L. M., Bello-Chavolla, O. Y.
10.1101/2021.03.11.21253402 — Posted: 2021-03-12
Quantifying Contact Patterns in Response to COVID-19 Public Health Measures in Canada
Brankston, G., Merkley, E., Fisman, D. N., Tuite, A. R., Poljak, Z., Loewen, P. J., Greer, A. L.
10.1101/2021.03.11.21253301 — Posted: 2021-03-12
Mean Vitamin D levels in 19 European Countries & COVID-19 Mortality over 10 months
Ahmad, A., Heumann, C., Ali, R., Oliver, T.
10.1101/2021.03.11.21253361 — Posted: 2021-03-12 Discussion: Onsite
Comparing COVID-19 risk factors in Brazil using machine learning: the importance of socioeconomic, demographic and structural factors
Baqui, P., Marra, V., Alaa, A. M., Bica, I., Ercole, A., van der Schaar, M.
10.1101/2021.03.11.21253380 — Posted: 2021-03-12 Discussion: Onsite
Leg-heel chest compression as an alternative for medical professionals in times of COVID-19
Ott, M., Krohn, A., Bilfield, L. H., Dengler, F., Jaki, C., Echterdiek, F., Schilling, T., Heymer, J.
10.1101/2021.03.09.21253220 — Posted: 2021-03-12
Comparison of SARS-CoV-2 detection in Saliva by real-time RT-PCR and RT-PCR/MALDI-TOF Methods
Hernandez, M. M., Banu, R., Shrestha, P., Patel, A., Chen, F., Cao, L., Fabre, S., Tan, J., Lopez, H., Chiu, N., Shifrin, B., Zapolskaya, I., Flores, V., Lee, P. Y., Castaneda, S., Ramirez, J. D., Jhang, J., Osorio, G., Gitman, M. R., Nowak, M. D., Reich, D. L., Cordon-Cardo, C., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.03.11.21253234 — Posted: 2021-03-12
Recovered not restored: Long-term health consequences after mild COVID-19 in non-hospitalized patients
Augustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., Horn, C., Vanshylla, K., Di Cristianziano, V., Osebold, L., Roventa, M., Riaz, T., Tschernoster, N., Altmueller, J., Rose, L., Salomon, S., Priesner, V., Luers, J. C., Albus, C., Rosenkranz, S., Gathof, B., Faetkenheuer, G., Hallek, M., Klein, F., Suarez, I., Lehmann, C.
10.1101/2021.03.11.21253207 — Posted: 2021-03-12 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).